Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Interferon-γ Activates Nuclear Factor-κ B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response.
Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature.
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt.
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
A novel monoclonal antibody against the C-terminal region of aquaporin-4.
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.
Neuromyelitis optica in child: diagnostic and therapeutic challenges.
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
Transverse myelitis following combined spinal-epidural anesthesia.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats.
Multiple sclerosis genetics.
Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Improving Safety and Operational Efficiency in Residential Care Settings With WiFi-Based Localization.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Pages
« first
‹ previous
…
297
298
299
300
301
302
303
304
305
…
next ›
last »